Consolidated Statements of Changes in Equity - USD ($) shares in Thousands, $ in Thousands	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Noncontrolling Interest	Total
Beginning balance at Dec. 31, 2023	$ 291	$ 409,980	$ (376,081)		$ 34,190
Beginning balance, shares at Dec. 31, 2023	29,092
Share-based awards and options exercises	$ 9	(9)
Share-based awards and options exercises (in shares)	883
Share-based compensation expense		1,338			1,338
Net loss			(7,873)		(7,873)
Ending balance at Mar. 31, 2024	$ 300	411,309	(383,954)		27,655
Ending balance, shares at Mar. 31, 2024	29,975
Beginning balance at Dec. 31, 2024	$ 557	446,938	(419,789)	$ 4,093	31,799
Beginning balance, shares at Dec. 31, 2024	55,679
Share-based awards and options exercises	$ 9	(1)			8
Share-based awards and options exercises (in shares)	941
Issuance of common stock, net of issuance costs of $1,731	$ 92	18,877			18,969
Issuance of common stock, net of issuance costs of $1,731 (in shares)	9,200
Share-based compensation expense		1,444			1,444
Net loss			(12,675)	(14)	(12,689)
Ending balance at Mar. 31, 2025	$ 658	$ 467,258	$ (432,464)	$ 4,079	$ 39,531
Ending balance, shares at Mar. 31, 2025	65,820